Key stats
About WisdomTree BioRevolution Fund
Home page
Inception date
Jun 3, 2021
Structure
Open-Ended Fund
Replication method
Physical
Dividend treatment
Distributes
Distribution tax treatment
Qualified dividends
Income tax type
Capital Gains
Max ST capital gains rate
39.60%
Max LT capital gains rate
20.00%
Primary advisor
WisdomTree Asset Management, Inc.
Distributor
Foreside Fund Services LLC
ISIN
US97717Y6187
WDNA provides exposure to developed market companies that will be significantly transformed by innovations in genetics and biotechnology over the medium- and long-term. Firms that meet size and liquidity screens must generate at least 50% of its revenue from the following BioRevolution sectors (as determined by Dr. Jamie Metzl): a) human health, b) consumer products, c) agriculture and food, d) materials, chemicals and energy, and e) biological machines and interfaces. Applicable financial filings are used to identify and evaluate eligible companies. The Index Committee will then determine the final list of holdings which are reconstituted and rebalanced semi-annually to a modified equal weighting. Although the fund launched with health care sector tilts, WDNA expects to have increased exposure to other related industries over the long-term because of the constant reinforcing of tech advancements in the genetics and biotechnology field.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks99.88%
Health Technology81.89%
Process Industries7.09%
Health Services6.04%
Technology Services2.66%
Consumer Non-Durables1.28%
Electronic Technology0.92%
Bonds, Cash & Other0.12%
Cash0.12%
Stock breakdown by region
North America79.68%
Europe19.00%
Asia1.07%
Oceania0.25%
Latin America0.00%
Africa0.00%
Middle East0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
WDNA invests in stocks. The fund's major sectors are Health Technology, with 81.89% stocks, and Process Industries, with 7.09% of the basket. The assets are mostly located in the North America region.
WDNA top holdings are Intellia Therapeutics, Inc. and CRISPR Therapeutics AG, occupying 3.96% and 3.13% of the portfolio correspondingly.
WDNA last dividends amounted to 0.11 USD. The year before, the issuer paid 0.14 USD in dividends, which shows a 26.05% decrease.
WDNA assets under management is 2.20 M USD. It's risen 7.01% over the last month.
WDNA fund flows account for 0.00 USD (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
Yes, WDNA pays dividends to its holders with the dividend yield of 0.72%. The last dividend (Dec 30, 2024) amounted to 0.11 USD. The dividends are paid annually.
WDNA shares are issued by WisdomTree, Inc. under the brand WisdomTree. The ETF was launched on Jun 3, 2021, and its management style is Passive.
WDNA expense ratio is 0.45% meaning you'd have to pay 0.45% of your investment to help manage the fund.
WDNA follows the WisdomTree BioRevolution Index. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
WDNA invests in stocks.
WDNA price has risen by 5.52% over the last month, and its yearly performance shows a −10.01% decrease. See more dynamics on WDNA price chart.
NAV returns, another gauge of an ETF dynamics, showed a 13.27% increase in three-month performance and has decreased by −9.34% in a year.
NAV returns, another gauge of an ETF dynamics, showed a 13.27% increase in three-month performance and has decreased by −9.34% in a year.
WDNA trades at a premium (0.55%) meaning the ETF is trading at a higher price than the calculated NAV.